During the past decade, University of Miami, Department of Neurology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Miami, Department of Neurology" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Elan Pharmaceuticals" with 1 trials as a collaborator and "University of Rochester" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Miami, Department of Neurology" are "Multiple Sclerosis" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials), "Parkinson Disease" (1 trials) and "Parkinson's Disease" (1 trials). Many other conditions were trialed in "University of Miami, Department of Neurology" in a lesser frequency.

Most popular intervention types in "University of Miami, Department of Neurology" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Coenzyme Q10 with vitamin E" (1 trials), "Fingolimod" (1 trials), "Fingolimod 0.5 mg" (1 trials) and "Fingolimod 1.25 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Miami, Department of Neurology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "University of Miami, Department of Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Miami, Department of Neurology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Miami, Department of Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".